Cargando…

1344. Interferon Gamma Release Assay (IGRA) Responses in HIV-Infected and -Uninfected Women in Pregnancy

BACKGROUND: Pregnancy and HIV-associated immunologic changes may affect latent TB infection (LTBI) interferon-gamma release assay (IGRA) QuantiFERON TB Gold Plus (QFT-Plus) diagnostic performance. METHODS: In this ongoing study, HIV-infected and -uninfected women 20–34 weeks gestation without TB in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaplan, Samantha, Matemo, Daniel, Mecha, Jerphason O, Kinuthia, John, John-Stewart, Grace, LaCourse, Sylvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808759/ http://dx.doi.org/10.1093/ofid/ofz360.1208

Ejemplares similares

Isoniazid preventive therapy during infancy does not adversely effect growth among HIV-exposed uninfected children: secondary analysis of data from a randomized controlled trial
por: Cherkos, Ashenafi S., et al.
Publicado: (2023)

Drop‐offs in the isoniazid preventive therapy cascade among children living with HIV in western Kenya, 2015–2019
por: Onyango, Dickens Otieno, et al.
Publicado: (2022)

Infant TB Infection Prevention Study (iTIPS): a randomised trial protocol evaluating isoniazid to prevent M. tuberculosis infection in HIV-exposed uninfected children
por: LaCourse, Sylvia M, et al.
Publicado: (2020)

A CD4+ TNF+ monofunctional memory T-cell response to BCG vaccination is associated with Mycobacterium tuberculosis infection in infants exposed to HIV
por: Warr, Alex J., et al.
Publicado: (2022)

Pulmonary tuberculosis screening in anti-retroviral treated adults living with HIV in Kenya
por: Gersh, Jill K., et al.
Publicado: (2021)

Serial Interferon-Gamma Release Assay (IGRA) Testing to Monitor Treatment Responses in Cases of Feline Mycobacteriosis
por: Mitchell, Jordan L., et al.
Publicado: (2021)

1476 Screening for Latent Tuberculosis Infection in Internationally Adopted Children in the era of Interferon-Gamma Release Assay (IGRA) Testing
por: Dhar, Cherie Priya, et al.
Publicado: (2014)

655. Patterns of Interferon-Gamma Release Assay (IGRA) Testing for Tuberculosis in Patients Less Than 2 Years Old
por: Tabatneck, Mary, et al.
Publicado: (2021)

Evaluation of the performance of two tuberculosis interferon gamma release assays (IGRA-ELISA and T-SPOT.TB) for diagnosing Mycobacterium tuberculosis infection
por: Wang, Linchuan, et al.
Publicado: (2018)

Detection of tuberculosis in cynomolgus macaques (Macaca fascicularis) using a supplementary Monkey Interferon Gamma Releasing Assay (mIGRA)
por: Warit, S., et al.
Publicado: (2020)

1377. Use of Interferon-Gamma Release Assays (IGRAs) Reduced Latent Tuberculosis Infection (LTBI) Diagnosis in Refugee and Immigrant Children
por: Kushner, Lauren E, et al.
Publicado: (2019)

1390. A Novel Application of the Interferon-Gamma Release Assay (IGRA) Among End-Stage Heart Failure Patients Awaiting Heart Transplantation
por: Tsai, Ming-Jui, et al.
Publicado: (2019)

Prevalence and risk factors for latent tuberculosis in polish healthcare workers: the comparison of tuberculin skin test and interferon-gamma release assay (IGRA) performance
por: Szturmowicz, Monika, et al.
Publicado: (2021)

789. Comparison of Interferon-γ Release Assays (IGRAs) for Diagnosis of Latent or Active Tuberculosis in Cancer Patients
por: Kulkarni, Prathit, et al.
Publicado: (2018)

Novel T cell interferon gamma release assay (IGRA) using spike recombinant protein for COVID19 vaccine response and Nucleocapsid for SARS-Cov2 response
por: Renaudineau, Yves, et al.
Publicado: (2022)

Importance of Inclusion of Pregnant and Breastfeeding Women in COVID-19 Therapeutic Trials
por: LaCourse, Sylvia, et al.
Publicado: (2020)

Screening for tuberculosis and the use of a borderline zone for the interpretation of the interferon-γ release assay (IGRA) in Portuguese healthcare workers
por: Nienhaus, Albert, et al.
Publicado: (2013)

Concordancia entre la prueba de la tuberculina y el Interferon Gamma Release Assay-IGRA en pacientes con enfermedades inflamatorias mediadas por la inmunidad
por: Catalán, Ignacio Pérez, et al.
Publicado: (2019)

Higher likelihood of 6-months exclusive breastfeeding among HIV infected than uninfected mothers: a household survey in Kenya
por: Okanda, John, et al.
Publicado: (2018)

A Pilot Study for the Evaluation of an Interferon Gamma Release Assay (IGRA) To Measure T-Cell Immune Responses after SARS-CoV-2 Infection or Vaccination in a Unique Cloistered Cohort
por: Barreiro, Pablo, et al.
Publicado: (2022)

Infliximab Therapy Leading to Pulmonary Tuberculosis in a Patient With Negative Interferon γ Release Assay (IGRA)-Based QuantiFERON Gold Test
por: Parita, Soni, et al.
Publicado: (2017)

Influenza-Induced Interferon Lambda Response Is Associated With Longer Time to Delivery Among Pregnant Kenyan Women
por: Seiler, Christof, et al.
Publicado: (2020)

An Immune Response to Heterologous ChAdOx1/BNT162b2 Vaccination against COVID-19: Evaluation of the anti-RBD Specific IgG Antibodies Titers and Interferon Gamma Release Assay (IGRA) Test Results
por: Zalewska, Marzena, et al.
Publicado: (2022)

Mycobacterial heparin-binding hemagglutinin (HBHA)-induced interferon-γ release assay (IGRA) for discrimination of latent and active tuberculosis: A systematic review and meta-analysis
por: Tang, Jinhua, et al.
Publicado: (2021)

TB prevention strategies and unanswered questions for pregnant and postpartum women living with HIV: the need for improved evidence
por: Mathad, Jyoti S, et al.
Publicado: (2020)

An Interactive Text Messaging Intervention to Improve Adherence to Option B+ Prevention of Mother-to-Child HIV Transmission in Kenya: Cost Analysis
por: Chen, Yilin, et al.
Publicado: (2020)

Commercial Interferon-gamma release assay to assess the immune response to first and second doses of mRNA vaccine in previously COVID-19 infected versus uninfected individuals
por: Tormo, Nuria, et al.
Publicado: (2022)

Maternal Tenofovir Disoproxil Fumarate Use in Pregnancy and Growth Outcomes among HIV-Exposed Uninfected Infants in Kenya
por: Pintye, Jillian, et al.
Publicado: (2015)

Assay design for unambiguous identification and quantification of circulating pathogen-derived peptide biomarkers
por: Shu, Qingbo, et al.
Publicado: (2022)

The Use of Interferon Gamma Release Assays in the Diagnosis of Active Tuberculosis
por: Vesenbeckh, Silvan M., et al.
Publicado: (2012)

Interferon-Gamma Release Assay Performance in Pulmonary and Extrapulmonary Tuberculosis
por: Feng, Yun, et al.
Publicado: (2012)

1760. Interferon Gamma Release Assay for Diagnosis of Lyme disease
por: Hefter, Yosefa, et al.
Publicado: (2018)

Draft Genome Sequence of Mycobacterium europaeum Strain CSUR P1344
por: Phelippeau, Michael, et al.
Publicado: (2015)

Chlamydia trachomatis-infected cells and uninfected-bystander cells exhibit diametrically opposed responses to interferon gamma
por: Ibana, Joyce A., et al.
Publicado: (2018)

Establishment of reference intervals during normal pregnancy through six months postpartum in western Kenya
por: Odhiambo, Collins, et al.
Publicado: (2017)

Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis
por: Doan, Tan N., et al.
Publicado: (2017)

Effect of pregnancy versus postpartum maternal isoniazid preventive therapy on infant growth in HIV-exposed uninfected infants: a post-hoc analysis of the TB APPRISE trial
por: Cherkos, Ashenafi S., et al.
Publicado: (2023)

Non-Tuberculous Mycobacteria and the Performance of Interferon Gamma Release Assays in Denmark
por: Hermansen, Thomas Stig, et al.
Publicado: (2014)

Effects of acute critical illnesses on the performance of interferon-gamma release assay
por: Huang, Chun-Ta, et al.
Publicado: (2016)

Interferon gamma release assay and tuberculin skin test positivity in sarcoidosis
por: Vyas, Sunil, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0vbi5i509epl4f9rm0k142d9to